RxDoctor Payments Data

Jehad Zakaria, MD

Neurological Surgery · Chicago, ILNPI 1225455181

Payments from drug & device makers

What this record shows

This record is dominated by grants: $50,000 of the $55,726 with a category attached, or 89.7%. Medtronic accounts for 94.1% of it on its own, with 23 other manufacturers making up the rest. Reporting peaked in 2023 at $50,967 and has fallen 97.9% since, to $1,045 in 2025.

$55,726in general payments, 2019–2025

Across 81 payments — averaging $687.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$52K
  • Stryker$1K
  • Siemens Medical Solutions USA, Inc.$378
  • Route 92 Medical, Inc.$346
  • Providence Medical Technology, Inc.$203
  • Medical Device Business Services, Inc.$178
  • plus $939 from 18 others

What the payments were for

  • Consulting fees$6251%
  • Grants$50,00090%
  • Travel & lodging$1,6893%
  • Food & beverage$2,9595%
  • Education$4501%
  • Gifts$40%

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$55,726 in reported general payments places this provider in the 85th percentile of 302 neurological surgery providers in Illinois.

See all neurological surgery providers in Illinois

Medicare billing

Part B allowed, 2024
$102,806
Medicare patients
152
Services billed
260

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Levetiracetam14$207

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →